Edwards Lifesciences Corp stock is traded at $105.43, with a volume of 4,271,213. It is down -1.57% in the last 24 hours and up +21.74% over the past month. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Previous Close:
$107.11
Open:
$106.22
24h Volume:
4,271,213
Relative Volume:
0.79
Market Cap:
$60.62B
Revenue:
$6.30B
Net Income/Loss:
$1.07B
P/E Ratio:
57.28
EPS:
$1.84
Net Cash Flow:
$1.09B
1W Performance:
+1.37%
1M Performance:
+21.74%
6M Performance:
+29.55%
1Y Performance:
+24.42%
1-Day Range:
$105.12$107.85
1-Week Range:
$104.93$108.00
52-Week Range:
$74.66$108.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences CorpSector
HealthcareIndustry
Medical DevicesPhone
(949) 250-2500Address
ONE EDWARDS WAY, IRVINE, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS